Dose-Independent Pharmacokinetics of a New Neuroprotective Agent for Ischemia-Reperfusion Damage, KR-31543, after Intravenous and Oral Administration to Rats: Hepatic and Intestinal First-Pass Effects

  • Lee, Mi-Hye (College of Pharmacy, Seoul National University) ;
  • Lee, Dae-Young (College of Pharmacy, Seoul National University) ;
  • Bae, Soo-Kyung (College of Pharmacy, Seoul National University) ;
  • Kim, Eun-Jung (College of Pharmacy, Seoul National University) ;
  • Kim, Yoon-Gyoon (College of Pharmacy, Seoul National University) ;
  • Kim, Sun-Ok (College of Pharmacy, Seoul National University) ;
  • Lee, Dong-Ha (College of Pharmacy, Seoul National University) ;
  • Lim, Hong (College of Pharmacy, Seoul National University) ;
  • Yoo, Sung-Eun (College of Pharmacy, Seoul National University)
  • Published : 2003.04.01

Abstract

The purpose of this study was to report dose-independent pharmacokinetics of KR-31543, a new neuroprotective agent for ischemia-reperfusion damage, after intravenous and oral administration and first-pass effects after intravenous. intraportal, intragastric, and intraduodenal administration in rats. After intravenous (10, 20 and 50 mg/kg) and oral (10, 20 and 50 mg/kg) administration, the pharmacokinetic parameters of KR-31543 were dose-independent. (omitted)

Keywords